SALBULIN
Brand-level analytics aggregated across all owners and jurisdictions using this name.
Total filings
6
Live
2
Live %
33.3%
Distinct owners
3
Jurisdictions
5
Top NICE
5Pharmaceuticals
Owners Using This Brand Name
| # | Owner | Country | Filings |
|---|---|---|---|
| 1 | RIKER LABORATORIES, INC. | US | 2 |
| 2 | Meda AB | SE | 1 |
| 3 | GRACEWAY PHARMACEUTICALS, LLC, | US | 1 |
| 4 | GRACEWAY PHARMACEUTICALS, LLC | US | 1 |
| 5 | Meda AB, | SE | 1 |
Geographic Coverage
Filing presence across major commercial IP offices. Color intensity is a log scale of filing count -- darker = more filings. Gaps may indicate expansion opportunities or unprotected markets.
Madrid Protocol (WIPO)
Less
More·Log scale
0 covered · 38 gaps · 38 target jurisdictions
Targets are major commercial IP offices. Gaps may indicate expansion opportunities or unprotected risk.
US○
United States
—
JP○
Japan
—
GB○
United Kingdom
—
IT○
Italy
—
TW○
Taiwan
—
EM○
European Union (EUIPO)
—
CN○
China
—
KR○
South Korea
—
HK○
Hong Kong
—
IN○
India
—
CA○
Canada
—
AU○
Australia
—
NZ○
New Zealand
—
DE○
Germany
—
FR○
France
—
ES○
Spain
—
CH○
Switzerland
—
NL○
Netherlands
—
BX○
Benelux
—
SE○
Sweden
—
NO○
Norway
—
PL○
Poland
—
TR○
Turkey
—
RU○
Russia
—
BR○
Brazil
—
MX○
Mexico
—
AR○
Argentina
—
AE○
United Arab Emirates
—
SA○
Saudi Arabia
—
IL○
Israel
—
ZA○
South Africa
—
SG○
Singapore
—
MY○
Malaysia
—
TH○
Thailand
—
ID○
Indonesia
—
PH○
Philippines
—
VN○
Vietnam
—
WO○
Madrid (WIPO)
—
By Jurisdiction
| Jurisdiction | Total | Live |
|---|---|---|
| TT | 2 | 0 |
| HU | 1 | 1 |
| PA | 1 | 0 |
| IE | 1 | 0 |
| SK | 1 | 1 |
Recent Filings
| Date | Owner | Status | NICE | App # |
|---|---|---|---|---|
| 1997-04-14 | Registered | 5 | 1036-97 | |
| 1997-03-20 | Registered | 5 | M9700978 | |
| 1989-10-13 | Cancelled | 5 | 50978-01 | |
| 1986-07-22 | Abandoned | 1 | N/M/1/016253 | |
| 1986-07-22 | Abandoned | 5 | N/M/1/016251 | |
| 1983-09-27 | Cancelled | 5 |